News
Article
Physician input needed: Do you prescribe semaglutide or other GLP-1RAs?
Author(s):
Are your patients asking about Ozempic and other GLP-1RAs? Are you prescribing it? Take our quick survey.
© Peter Hansen - stock.adobe.com
One of the hottest topics in medicine right now is the potentially revolutionary use of Glucagon-like peptide-1 receptor agonist (GLP-1RAs) drugs to manage overweight/obesity. These medicines are popularly known to patients by brand names like Ozempic or Wegovy.
We value your expertise! We're conducting a brief survey to gather insights from physicians like you on physician use and perceptions of GLP-1RA drugs for managing obesity.
Your feedback will be instrumental in helping us create content to inform physicians about this rapidly developing space.
The survey takes only 5 minutes to complete, and all responses are anonymous.
Newsletter
Stay informed and empowered with Medical Economics enewsletter, delivering expert insights, financial strategies, practice management tips and technology trends — tailored for today’s physicians.
